Sign in to view Breezy’s full profile
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
Seattle, Washington, United States
Contact Info
Sign in to view Breezy’s full profile
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
2K followers
500+ connections
Sign in to view Breezy’s full profile
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
View mutual connections with Breezy
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
View mutual connections with Breezy
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
Sign in to view Breezy’s full profile
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
Experience & Education
-
SkinnyDipped
***
-
**** ****** ****** ****** ****** *******
******* *** ***
-
*** ********** ** ******* ********
******** ** **** (**) **********
-
View Breezy’s full experience
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
View Breezy’s full profile
Sign in
Stay updated on your professional world
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
Other similar profiles
-
Lizzie Resta
Seattle, WAConnect -
Rohan Oza
United StatesConnect -
Mark Clagg
Seattle, WAConnect -
Jessica Bieber
Baltimore City County, MDConnect -
Keith Brisack
Irvine, CAConnect -
Rachel Kusin
Austin, TXConnect -
Chrissy Haller
Denver, COConnect -
Ben Van Leeuwen
Brooklyn, NYConnect -
Mariah Quintanilla
Social + Brand Engagement at SkinnyDipped
United StatesConnect -
Erin Korte
Seattle, WAConnect -
Taylor Walker
United StatesConnect -
Walker Howard
Graphic Designer at SkinnyDipped
United StatesConnect -
Diana Levy
Short Hills, NJConnect -
Hamdi Ulukaya
New Berlin, NYConnect -
Ashley Thompson
Greater Chicago AreaConnect -
Anthony Zottarelli
San Francisco, CAConnect -
Chelsea Wallin
Greater PhiladelphiaConnect -
Sarah Donaldson
Director of Sales Planning at SkinnyDipped
Seattle, WAConnect -
Alexandria Callahan
Creative, Graphic Designer, content creator and Yoga Teacher
San Diego, CAConnect -
Gabi Lewis
New York, NYConnect
Explore more posts
-
Joshua Novick
🌿 Despite #high hopes, the #cannabis industry has faced significant challenges. Turns out, it's not as #dope as investors toked it'd be. 📉 The leading player, Curaleaf, saw its value drop from a peak of 💲11.5B in 2021 to 💲4B today, highlighting the downturn in #marijuana stocks. The #market: 💰 Total U.S. Cannabis Market (legal + illegal) is valued at 💲75B, while the the legal US TAM, currently 💲32B, expected to grow to 💲43B by 2027 (source: BDSA) 🗽Just the New York state TAM is a hefty $6 billion cannabis market (and if you've strolled through NYC lately, you'll know it's not just the hot dog vendors adding to the aroma). 🌿 🍺 In comparison, the U.S. #Alcohol Market was valued at $247B in 2021, with the beer market alone at $115 billion, a stark 8x times cannabis TAM. 💼 Diageo, the leader in the spirits market boasts a 💲76B market cap, 💲21B in revenue and over 💲4B in net income. AB InBev, the leader in beer, commands a 💲120B market cap, 💲60B revenue and 💲5B net income. Some analysts believe that if a cannabis leader emerges, it might eventually reach similar figures. A long way to go for Curaleaf and others... 🌍 Besides the US and Canada there's potential in Europe with countries like Germany, Poland, and the UK that loosening cannabis regulations. More are expected to come. The #issues: 💸 Profitability hurdles include prohibitive taxes, with cannabis businesses unable to deduct common expenses, resulting in significant tax burdens despite losses in net income. 🤝 Fragmentation plagues the industry, with no player holding substantial market share, signaling a potential need for consolidation through mergers. 📊 Data on major companies: 📈 Revenue (2023) Curaleaf - $1.35B Trulieve - $1.22B Green Thumb Industries (GTI) - $1.02B Verano - $879M Cresco Labs - $825M 💹 Gross Margin (2023): Trulieve Cannabis Corp. - 52% Verano Holdings - 51% Green Thumb Industries Inc. - 49% Cresco Labs Inc. - 48% Curaleaf Holdings, Inc. - 45% 💼 EBITDA (2023): Green Thumb Industries Inc. - $291M Verano Holdings - $284M Trulieve Cannabis Corp. - $263M Curaleaf Holdings, Inc. - $239M Cresco Labs Inc. - $125M 👥 Total Employees: Curaleaf Holdings, Inc. - 5,650 Trulieve Cannabis Corp. - 5,400 Green Thumb Industries Inc. - 4,561 Verano Holdings - 3,900 Cresco Labs Inc. - 2,760 💼 Market Cap (may 3rd 2024): Curaleaf Holdings, Inc. - $4.17B Green Thumb Industries Inc. - $3.13B Trulieve Cannabis Corp. - $2.33B Verano Holdings - $1.75B Cresco Labs Inc. - $1B Fast forward a decade, where do you envision the cannabis industry? Do you anticipate pharmaceutical companies making their mark in the cannabis market? Could tobacco or alcohol giants venture into cannabis diversification?
35
3 Comments -
Sajag Agarwal
You’ve got a well-crafted product and a brand new distribution partner. What’s next? Just ask HashStash. THE BACKGROUND 🍃 Hash Stash is a fast-growing consumer brand that makes accessory and storage boxes for recreational cannabis products. 💵 In just a few short years, the company has grown from a boutique online shop to a thriving ecommerce brand employing 10 people and generating over $4 million in yearly revenue. THE PROBLEM 🚛 In their first year and a half of business, the Hash Stash team sold exclusively on Amazon. 🛍 Then, they decided that Shopify would actually be a better fit for their business and its unique needs. 🔎 As their business grew, the Hash Stash team needed a partner that would be able to provide a world-class inspection process. That’s when the company’s COO, Clara Mae Silvestre, discovered Movley. THE SOLUTION 🏭 Movley was able to create an entirely new and improved inspection process that was specifically designed for Hash Stash’s unique product and dedicated suppliers 📋 Movley’s inspection reports provide: - An assessment of why each has passed or failed - Photos and videos of what each product looks like - A list to identify which products are missing components - Thorough reports with inspection and QC recommendations 📣 “Their team is so alert and attentive to our requests and always makes sure their reports after inspection are thorough and detailed.” — Clara Mae Silvestre, COO THE RESULTS 🤝🏻 Hash Stash and Movley have built a successful, long-term partnership between the two teams. 📈 Movley is able to grow alongside Has Stash. Now, years later, Movley helps inspect over 10,000 units per month. 📉 Consequentially, Hash Stash’s return rate has dropped to less than 1%! Want to learn more about Movely can help improve your QC efforts? Check out the entire Hash Stash case study below 🍃
7
1 Comment -
Krista Raymer
3 Cannabis Product KPIs- most operators don't look at Whether you're a dispensary or a vertically integrated operator, understanding how customers interact with your products is crucial for making assortment decisions and monitoring loyalty. You've likely seen products hit the shelves with a bang, only for sales to fizzle out within 60 days. This often happens because the product fails to drive repeat purchases from most customers. Track these three key performance indicators (KPIs) 1. Follow-up Purchase Rate (%): How many transactions containing Product X resulted in a subsequent purchase from the same customer, regardless of the product? 2. Repeat Purchase Rate (%): How many orders containing Product X resulted in a repeat purchase of the same product? This metric is especially important for vertically integrated brands or products where you want to cultivate customer loyalty. 3. Customer Lifetime Value ($): What is the annual value of customers who bought Product X during their first visit? Where do you apply these insights? → Customer acquisition and retention campaigns →In-store product placement and merchandising → With budtenders and store managers to build selling confidence. These KPIs provide valuable insights into what products are selling, when, and to whom. While budtenders and managers may instinctively know the top-selling brands or products, these metrics unveil hidden gems or underperformers that deserve closer attention. These KPIs can help you/your teams make data-driven decisions that optimize your product mix, improve customer experiences, and ultimately drive revenue growth.
53
1 Comment -
Elaine Watson
What's next for Beyond Meat after another set of grim quarterly figures? - Net revenue: -18% year over year (YoY) to $75.6m, volumes +8% - Net loss: $54.4m - Margins: Gross profit was $3.7m with a gross profit margin of 4.9% - US retail revenues: -16% YoY to $37.1m - US foodservice revenues: -16.2% YoY to $12.3m - International retail: -12% YoY to $12.6m - International foodservice: -28.7% YoY to $13.6m - Full year 2024 outlook: Net revenues $315-345m, with gross margins in the mid to high teens - Balance sheet: As of March 30, cash and cash equivalents balance of $173.5m and total outstanding debt at $1.1bn #foodtech #alternativeprotein #meatalternatives #altmeat #plantbased #plantbasedmeat AgFunder
44
13 Comments -
Cullen Raichart
Change is coming in the cannabis industry and opinions are split on whether it's good or bad. But one thing is for sure, it will be different. While some see this change as a potential positive, others fear that it could lead to pharma control. There are potential benefits such as the impact on banking and the 280E, but it remains to be seen whether these will truly help the industry. Regardless, the fact remains that federal regulations are on the horizon. Brace yourselves, change is upon us. #CannabisIndustry #Regulations #Change
5
-
crames lawless
F the Treaties: Rescheduling and Marijuana-Particular Controls https://lnkd.in/gwnhJv2Z <a href=""> - Marijuana-specific controls in schedule III? The drug Enforcement Administration (DEA) revealed its Discover of Proposed Rulemaking (“NOPR”) final week to a lot fanfare. The NOPR would reschedule marijuana, “marijuana extract” and “naturally derived delta-9 tetrahydrocannabinols” from schedule I to schedule III of the Managed Substances Act (CSA). However that’s not all. In my very fast evaluation after the rule dropped, I flagged DEA’s assertion that it might develop “marijuana-specific controls” together with rescheduling. I’m shocked this DEA assertion hasn’t spurred a lot dialogue, regardless of its Easter egg placement at NOPR web page 86. “Marijuana-specific management” guidelines might turn into a reasonably large deal. For context, the U.S. is a celebration to sure worldwide treaties that require it to regulate hashish and different drugs. Due to that obligation, the Division of Justice’s Workplace of Authorized Counsel (OLC), has suggested DEA that extra controls could also be wanted for marijuana on schedule III. That’s the best method to clarify it: if you need extra element on the whys and wherefores of the authorized regime and OLC’s rationale, go to pages 83-87 of the NOPR. In my publish final week, I highlighted that marijuana-specific controls could be thought of by DEA “concurrent with this rulemaking.” In different phrases, DEA is saying, “we’re taking a look at adopting new and particular guidelines for marijuana, past simply shifting it to schedule III. However we don’t know what these new and particular guidelines could be but. Keep tuned.” This strategy is artfully imprecise and noncommittal, and awkward, and begs examination. The trail to marijuana-specific controls I’m not an administrative legislation knowledgeable. Nonetheless, my understanding is that DEA could be required to note any proposed, marijuana-specific management guidelines within the Federal Register and open them up for remark. In different phrases, the method would mirror what we simply noticed with final week’s NOPR. If this occurs, it is going to be attention-grabbing to see what the “particular controls” guidelines present. To that finish, I’m not conscious of any such guidelines for different schedule III drugs. As a substitute, there are solely basic controls relevant to all schedule III drugs: e.g., sure storage necessities, allowances for paper or phone prescriptions, refill caps, and many others. None of that appears relevant to e.g. marijuana flower, which isn’t authorised by FDA for something. Alternatively, what might these guidelines probably say that might matter, particularly with respect to state marijuana packages? Would anybody, outdoors of scientists learning marijuana, pay any consideration to a DEA’s “particular controls” for sched...
1
-
Matthieu Vincent
🧪🌱 Molecular farming (1/2) the new kid in the alt protein block Trends are moving fast in this space (at least in terms of hype; when we talk about real, measurable output, it's much slower). => A year ago, the spotlight was on cellular agriculture startups as a couple gained regulatory approval for their meat products in the US. However, their inability to scale quickly put a shadow on that trend, which is now moving fast toward the pit of disillusion. => Then, precision fermentation, using micro-organisms to produce proteins through fermentation, climbed to the top of the hype as numerous startups received regulatory approval while announcing large-scale facilities and new products. For similar reasons (scale), the hype has watered down. So, is it over, and are we waiting for these technologies to be mastered or used differently (for new ingredients, for example, coffee, sugar, or cacao)? Obviously not; there is a new hot tech in town: molecular farming. 📊 Below is DigitalFoodLab’s hype curve with the current state of the different alternative protein technologies. Molecular farming is moving forward with increasing speed. From a niche topic that was barely considered between 2021 and the end of 2023, it has become a major topic of discussion in the overall alternative protein ecosystem. 👉 Link in the comments with the full insight 👉 Tomorrow, the follow-up with Molecular farming definition and applications. #alternativeproteins #foodtech #trends
37
2 Comments -
Russ Conser
Cultivated meat: a fairly quick boom and bust seemingly in its waning days already. Although folks want to blame the market, I would suggest the challenges to cost reductions and scalability are fundamental, not simply cyclicality. Its challenges have deep roots in thermodynamics when the competition is based on free sunshine and the natural, autonomous, self replicating, self-healing technology of evolution. There will plausibly be value in IP for other applications, so maybe investors get a few pennies out for their dollars? https://lnkd.in/gd4rYET5
18
4 Comments -
Steve Molino
🥩 Meat vs 🥗 Plant-based vs 🍄 Fungi vs 💯 Cultivated --> As the alt protein market shifts, where do we draw the line between them as combinations emerge? GOOD Meat (Eat Just, Inc.) is always good for a headline, and this week they announced they're the first-ever cultivated company to release products in retail after launching a cultivated chicken product in the frozen section of Huber's Butchery in Singapore. 😲 Seemed cool at first, but we then learned the products contained 3% cultivated cells and 97% plant-based ingredients. Yes, you read that correctly. Three percent. 📢 Sonalie and I share our thoughts on this in this week's episode (link in comments), and I end up going on a bit of a rant as, it turns out, I really don't think much of this announcement. There are questions around the reason for doing this (just to be the first, investor pressure, etc?), if there's value to being the first to retail, if 3% is all that's needed to completely change the experience of the product vs 100% plant-based, etc. ⁉ But a really interesting question that was raised is at what % inclusion does a plant-based or mycelium/fungi product become a cultivated product? Where do we draw the line in the sand? 1% 3% 10% 25% Etc. Etc. 🤔 Does adding 3% of cells really make it go from plant-based to cultivated? How do we justify a specific number being meaningful? Is it simply whatever number that results in consumers being open to switching from conventional animal products? Will that number vary by meat type (I'd have to imagine so)? Will the masses be happy with, or interested in, anything less than 80%+ (I pick 80% because 80/20 beef/fat is very common - at least in the US)? 🤔 I think the % that matters is whatever number that will result in the masses of consumers being open to switching away from conventional animal products - but, again, we don't even know what that number is, and at this point it could very well be 100% What do YOU think? Genuinely want to hear everyone's thoughts. _______________________________________________________________ Separately, this week's episode also hits on: 🌱 Peter McGuinness of Impossible Foods shares thoughts on the plant-based sector w/ Bloomberg. A lot we agree with, such as the failure of the initial messaging in the space and what needs to change. Sonalie also makes me sound like a lying monster for saying it's okay to make the messaging of a mission-driven company NOT centered around the mission! Fun haha 🥚 I share how I'm extremely excited by this new about The Vegetarian Butcher and The EVERY Company, as it's what the space has been created for; HOWEVER, I do need to call out here that I may have gotten over-excited, as I may have missed the point that it's being used as a CMC replacer vs conventional egg. Need to learn more! Arturo 🇰🇷 Sonalie shares the positive of the week, which is the amazing government progress/support for sustainable foods in South Korea - could be the next Singapore!
92
34 Comments -
Mitchell Osak
Cannabis Firms, You Can Take Up Pricing “Pricing is by far the biggest tool for earnings improvement." McKinsey & Co. Almost every cannabis business is caught in a vise of rising costs and declining pricing levels, exacerbated by relentless competition and rapid product turnover. This nasty reality can be mitigated. Whilst cannabis firms are generally price takers, they often have brands and SKUs where they can take up pricing with minimal volume or brand risk. This is a compelling opportunity when you do the math. Modest across-the-board price increases (say 3% to keep pace with inflation) can boost bottom line profitability by 25%. In cannabis, I’ve worked on selected pricing initiatives in high switching categories that have increased Return on Sales by 4-7%. 'Selective' is the key word when it comes to price increases. Cannabis brands typically feature high volume & inventory risk; price adjustments come with execution costs and; there are risks of decoupling your pricing and brand strategies. Leaders would be ill-advised to ignore price increases as a means of boosting financial and brand performance. Capitalizing on these opportunities, however, takes work, including: financial and demand elasticity modelling, market/consumer research and total quality implementation. Here are 3 ways to ‘price to win’: 1. Align your pricing to value delivered, market differentiation and consumer interest. If your product has lots of consumer-relevant features, is unique or competes in a sleepy category then you have pricing power. Use it to get capture higher margins. Some marketers should also be mindful that consumers have a hard time believing you are a premium brand if the product is priced in the value segment. In this case, taking up pricing could paradoxically lead to higher volume. 2. Message better Channels and consumers understand inflation; they also live it. How you position and communicate a modest price increase can be the difference between success and failure. And it never hurts to test your pricing hypothesis in a controlled pilot. 3. Build long term capability Pricing management should be a shared competency and responsibility between sales, marketing and finance. Regularly monitor your costs, competition, and channel needs to ensure your pricing strategy consistently delivers on corporate goals. 🔔 Hit that follow bell to always get my unique, impactful content #cannabisindustry #pricing #cannabis #Mckinsey #revenue #brands #MSOS #LPS
14
2 Comments -
Sandra Bergman
Brand loyalty doesn't exist in cannabis yet. No c@nn@bis brands are pulling the cultural & psychological levers to drive customers to develop a long-lasting connection. Rather, the crux of all c@nn@bis loyalty programs is receiving points/rewards/discounts, which is transaction-based instead of relationship-based. So customers have little to no emotional tie with a brand. As more and more adult-use markets come online, customers are quick to leave a retailer when something closer becomes available to them. Convenience is king. In addition customers can be easily swayed to a different brand with promotions and discounts. Plus, there's not a lot of clear differentiation among retailers, either in products available or customer experience. Agree? Disagree?
68
66 Comments -
Quinn McKenna
Consider how dog food is marketed. The end user cannot read the claims made on the package. Fido doesn’t care if it is organic, grain-free, made with whole grain, or deboned chicken is our #1 ingredient! Fido is going to eat it, more than likely, if you give it to him. Dog food, like most products, is marketed to the purchaser, not the user. I think the Dog Food Marketing principal contributes to the abundance of restaurant tech solutions intended to help operators better understand operating metrics. These products are marketed to C-suite management teams (I should know, I am one). When you focus on the spreadsheet possibilities of performance enhancement, it’s understandable that tools designed to provide “additional insights” sound like they could be helpful. And since we C-suite restaurant execs are the ones writing the checks for new tools, we support their proliferation. What’s the old saying? To a hammer, every problem looks like a nail. How about looking at this differently? If you are trying to lose a few pounds, it’s not likely that your first step would be to buy a more accurate scale. There’s an opportunity for meaningful improvement in business profitability in using new tools to achieve new levels of efficiency. No, I’m not talking about replacing cooks with robots either. Why not supply our teams with tools to support organization and efficiency? PS. That’s what we are building at Byte Kitchen
9
2 Comments -
Derek D'Ambrosio
🚨 Insightful DEA Report: Illicit marijuana flowers average a THC potency of 16%. 🌿💨 This statistic underscores a significant advantage of purchasing from licensed dispensaries—quality and safety. Unlike the unregulated market, dispensaries offer products that are tested, compliant, and consistent in their THC content. This not only ensures a safer consumer experience but also supports the legal cannabis industry committed to high standards. Why risk the unknown? Choose quality, safety, and reliability every time with dispensary-bought cannabis. Let's advocate for more informed consumer choices and support regulations that emphasize these benefits. Stay informed and choose wisely. #CannabisIndustry #ConsumerSafety #DispensaryQuality #THCPotency #RegulatedCannabis
19
7 Comments -
Theresa Dobrash
New York's $200 million Social Equity Cannabis Investment Fund has been quietly shut down amid allegations of predatory lending. Reports surfaced of a private equity firm, Chicago Atlantic, providing $50 million at a 15% interest rate, with loans exceeding actual contractor costs by three times and carrying over 10% interest rates. Confirmation Hearing Highlights: Robert Rodriguez: Recently appointed acting president of DASNY, was questioned by lawmakers. Sen. Liz Krueger: Raised concerns over the lack of competitive bidding for construction contracts and contradictory information about ongoing deals with Chicago Atlantic. Chicago Atlantic: Provided $150 million for the fund and committing an additional $150 million for site purchases and buildouts. Main negotiator with licensees. Rodriguez’s Defense: Defended high interest rates as lower than typical commercial cannabis loans. Acknowledged high construction costs and committed to improving transparency. Attributed issues to litigation injunctions and the illicit market. Concerns Raised: Lawmakers called for audits, citing discrepancies in construction costs. Concerns over licensees' ability to repay loans and potential store seizures. Current Status: Governor Kathy Hochul’s administration has quietly ended the fund amid these controversies. Reflects ongoing difficulties in establishing an equitable cannabis market in New York since legalization two years ago. https://lnkd.in/gcjw66xf
5
-
Kosuke Shibata
Japan's THC regulations are about to get a lot tougher. At the end of 2023, the Japanese government made the first fundamental reform of the Marijuana Control Law, which was created with the U.S. GHQ after the Second World War. Elimination of site restrictions and introduction of ingredient restrictions, where previously only stems and seeds were legal. From a ban on its use as a medical treatment to a permit requirement. This clears the way for Epidiolex and Sativex. Other cultivation will also be liberalized as long as the cultivation is less than 0.3% THC. However, for final products, it appears that much stricter values are required. Only 10 mg/kg (10 ppm, 0.0001%) for oil status, 0.1 mg/kg (0.1 ppm, 0.000001%) for beverages, and less than 1 mg/kg (1 ppm, 0.00001%) for other (edibles, cosmetics, etc.) THC content is allowed. In particular, raw materials are currently interpreted as being classified as "other," but a value more stringent than oil would clearly not pass logic, so a category of oil value or "raw materials" could be created. The THC content of the raw material is estimated at a low of 10 ppm and a high of 20 ppm. This is still a much tighter value. We need to re-examine our raw materials and would like to hear from any third-party labs that can reliably guarantee 10 ppm THC (Δ8, Δ9, THCA, THCV, etc., total THC system) in CBD isolates or any other component isolates. Or refer me to one. https://t.co/p3u0Nfc0Zq
1
-
Jose Lugardo Espejel
Most new cannabis markets start under some assumptions about how they will play out: 1. Tobacco, alcohol, pharma regulation can be used to develop successful cannabis markets. 2. Legality will bring legacy players on board automatically. 3. Consumers will conform to rules. These assumptions are optimistic at best.
-
Mitchell Osak
How Does Big CPG Look at Cannabis? A few weeks ago, I assessed how Big Tobacco will step further into the cannabis space. This time, we'll consider consumer packaged goods companies. In our industry, few topics generate as much heat - and as little light. To best answer the question, it helps to be employed at a CPG firm or work closely with them. I’m fortunate to have done both (at P&G, Maple Leaf Foods and SC Johnson). CPG is a loose collection of national and global companies that sell everyday products like food, alcohol and household products to consumers. CPG firms focus on uncovering consumer insights, creating IP and building differentiated brands. The large players typically compete in mature markets and leverage sophisticated practices and consumer data to develop multi-year strategic plans. Why should cannabis firms care about CPG? > LPs & MSOs will need to play defence when more CPG firms enter the sector; > CPG firms can provide an M&A exit, world class capabilities and capital to a worthy weed company; > Despite differences, cannabis businesses can learn a lot from their CPG peers. I have consulted to some CPG firms who were thinking about entering the cannabis and CBD markets. The scopes of work can give you a sense of what CPG really care about and how they might enter the cannabis space. In each case, my strategy and analytical work focused on 3 areas: 1. Defining the real market CPG cares a lot about choosing profitable markets and segments to compete in. Big CPG needs to capture significant shares of large markets to justify the capital and organizational investment. These generation 2.0 CPG players are also not naïve or overly exuberant. They won’t fall for TAM fantasies or be seduced by the performance of legacy MSOs and LPs. 2. Identifying material risks These are risk-aware companies. A ‘test & learn’ approach will be the entry path of some firms. They understand that you make money by not squandering it and by ensuring your limited capital is deployed in the best 'risk vs reward' situation. Furthermore, CPG take things like product safety, regulatory compliance and ESG very seriously. 3. Understanding the regulations: today and tomorrow As expected, CPG want to know what’s allowed and not allowed by market. Furthermore, they want to understand what the path to legalization or relevant reform is. Two other strategic questions inevitably entered the strategy deliberations: - Can you differentiate and win at the consumer & trade level? - What is the fit with their existing capabilities and assets? Some LPs have danced with CPG partners and investors, with less than ideal results. These are more teething pains and less an indictment of the CPG-cannabis fit. Our sector has barely felt the impact of the big CPG players. That moment will soon come. 🔔 Hit that follow bell to always get my unique, impactful content #cannabisindustry #CPG #cannabis #FMCG #cannabis #strategy
73
44 Comments -
Jason W. Ingle
Five years ago today, on May 2nd 2019, Beyond Meat began trading on the NASDAQ as a public company. At the time, it was the most successful IPO in more than 20 years, and its market value would soar to over $10 billion, becoming a rarified “decacorn.” But recently, the alt-protein movement has faced setbacks and adversity, calling into question whether or not the plant-based “revolution” we were promised is indeed coming. In my newest Third Nature Investments blog, I reflect on being an early investor in Beyond Meat, the environmental and human health benefits of alternative protein, the challenges to overcome, and where we go from here. Read it here: https://lnkd.in/gFH4tM2i #systemicinvesting #plantbased #climatechange #altprotein
51
6 Comments -
Antonia ☆ Whyte
Here are some recent cannabis-related news articles 1. **"How Big Caps Rewrite Valuation Rules in Cannabis: Cash Puzzle For Companies Above And Below $500M"**: - This article discusses how cash flow is assessed for cannabis companies and the methods used to determine their value¹. 2. **"Worker Fired for Positive Cannabis Test Wins Another Court Ruling"**: - A worker who was fired after testing positive for cannabis (which had been prescribed for back pain) won a court ruling. The judge awarded $191,000 in damages and added legal fees². 3. **"New Abington Cannabis Shop Aims for Sweet Spot — Natural Products at 'Lowest Price Possible'"**: - Co-owner Gary Leonard of a new cannabis shop in Abington, Massachusetts, emphasizes natural products and affordability. Customers are trying out these products with smiles on their faces³. Source: Conversation with Bing, 4/30/2024 (1) How Big Caps Rewrite Valuation Rules In Cannabis: Cash Puzzle For Companies Above And Below $500M. https://lnkd.in/gmm6wkMg. (2) Worker fired for positive cannabis test wins another court ruling. https://lnkd.in/g_w2PpWT. (3) New Abington cannabis shop aims for sweet spot — natural products at 'lowest price possible'. https://lnkd.in/geFnaMBp. (4) Marijuana Moment - All your cannabis news, in one place. https://lnkd.in/ddyd49ZG. (5) Past News Articles | High Times Magazine. https://lnkd.in/gfXSXAGD. (6) The Latest Cannabis News Today | Leafly. https://lnkd.in/g33aatHh.
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More